MarketLens
Sign Up

What's Driving Phathom Pharmaceuticals' Recent Momentum

7 months ago
SHARE THIS ON:

What's Driving Phathom Pharmaceuticals' Recent Momentum

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•2 weeks ago

PHAT Investors Have Opportunity to Join Phathom Pharmaceuticals, Inc. Fraud Investigation with SBS Law

SBS Law opened a fraud investigation into Phathom Pharmaceuticals (PHAT), inviting investors to join. No financial terms, class period, or allegations were disclosed in the notice.
Stock News•2 months ago

Phathom Pharmaceuticals Q2 Earnings Call Highlights

Phathom Pharmaceuticals reported Q2 2026 revenue growth of 88% YoY and achieved positive operating profit (excl. stock-based compensation) one quarter ahead of plan.
Stock News•2 months ago

PTGX Stock Surges 64% in Six Months: What Is Driving the Rally?

PTGX stock surged 64% in six months, driven by rusfertide's nearing FDA decision and Icotyde's milestone payments, royalties, and pipeline momentum.

Breaking News

View All →

Top Headlines

View More →
Stock News•2 hours ago

Forget the S&P 500: SCHD Is Beating It by Nearly 10 Points in 2026 and Its Dividend Just Grew

Stock News•4 hours ago

NVDY: NVIDIA Shares Break To Record Highs, Don't Cede The Upside Now

Stock News•6 hours ago

Is Copilot Microsoft's Secret Weapon in the AI Arms Race?

Stock News•7 hours ago

2 Millionaire-Maker Quantum Computing Stocks to Buy Hand Over Fist

Stock News•7 hours ago

The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It